Search
Fibrobiologics Inc
FBLGAdd to Watchlist
0.875USD
-0.031-3.40%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
2.91MMarket Cap
LossP/E TTM
More Details of Fibrobiologics Inc Company
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). It is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. It is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.
Fibrobiologics Inc Info
Ticker SymbolFBLG
Company nameFibrobiologics Inc
IPO dateJan 31, 2024
CEOO'Heeron (Pete)
Number of employees13
Security typeOrdinary Share
Fiscal year-endJan 31
Address455 E. Medical Center Blvd
CityHOUSTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code77598
Phone12816715150
Websitehttps://fibrobiologics.com/
Ticker SymbolFBLG
IPO dateJan 31, 2024
CEOO'Heeron (Pete)
Company Executives of Fibrobiologics Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ruben Garcia
Mr. Ruben Garcia
General Counsel
General Counsel
9.00K
--
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Director
Director
375.00
--
Dr. Victoria Niklas, M.D.
Dr. Victoria Niklas, M.D.
Independent Director
Independent Director
--
--
Mr. Richard Cilento, Jr.
Mr. Richard Cilento, Jr.
Independent Director
Independent Director
--
--
Ms. Stacy Coen
Ms. Stacy Coen
Independent Director
Independent Director
--
--
Mr. Matthew Link
Mr. Matthew Link
Independent Director
Independent Director
--
--
Mr. Pete O'Heeron
Mr. Pete O'Heeron
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Nic Johnson
Mr. Nic Johnson
IR Contact Officer
IR Contact Officer
--
--
Mr. Jason D. Davis
Mr. Jason D. Davis
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ruben Garcia
Mr. Ruben Garcia
General Counsel
General Counsel
9.00K
--
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Director
Director
375.00
--
Dr. Victoria Niklas, M.D.
Dr. Victoria Niklas, M.D.
Independent Director
Independent Director
--
--
Mr. Richard Cilento, Jr.
Mr. Richard Cilento, Jr.
Independent Director
Independent Director
--
--
Ms. Stacy Coen
Ms. Stacy Coen
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Fibrobiologics Inc?
The top five shareholders of Fibrobiologics Inc are: Mr. Ruben Garcia
How many institutions hold shares of Fibrobiologics Inc (FBLG)?
As of 2026Q1, 139 institutions hold shares of Fibrobiologics Inc, with a combined market value of approximately 258.88K, accounting for 4.97% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -83813.00.